Table 3.
Self-reported cancer site and year of diagnosis accuracy among ATP participants who correctly report overall, common, and rare cancer status.
| Including those with cancer diagnoses before baselinea | Excluding those with cancer diagnoses before baselinea | |||||||
|---|---|---|---|---|---|---|---|---|
| % TP's that also have correct | % TP's that also have correct | |||||||
| # TP's | Site only | Site and year ± 1 | Site and year | # TP's | Site only | Site and year ± 1 | Site and year | |
| Common | 649 | 97.5 | 95.1 | 73.3 | 645 | 97.5 | 95.0 | 73.5 |
| Common (excl. skin) | 600 | 97.8 | 95.5 | 73.7 | 596 | 97.8 | 95.5 | 73.8 |
| Rare | 54 | 77.8 | 74.1 | 61.1 | 53 | 77.4 | 73.6 | 60.4 |
| Rare (excl. cervix) | 52 | 76.9 | 73.1 | 61.5 | 51 | 76.5 | 72.5 | 60.8 |
|
| ||||||||
| Overallb | 746 | 90.5 | 88.1 | 68.2 | 741 | 90.4 | 88.0 | 68.3 |
ATP: Alberta's Tomorrow Project; TP: true positive; excl.: excluding. a A participant had a diagnosis before baseline if their age of first cancer diagnosis in the ACR was before their age at baseline. b Overall TP does not equal common TP plus rare TP. An overall TP reported cancer and had cancer in the ACR, regardless of type. A participant with a common cancer in the ACR had to report a common cancer in order to be a common TP. Similar criterion defines a rare cancer TP.